|
|
News Breaks | | | | September 4, 2012 | | 07:49 EDT |  | DRTX | Durata Therapeutics reports Q2 net loss $19.2M
Durata Therapeutics reported a net loss for the three months ended June 30 $19.2M, compared to net loss of $11.5M for the three months ended June 30, 2011. Research and Development expense for Q2 was $16.5M, compared to $8.4M for the 2011 Quarter. As of June 30, the company had cash and cash equivalents of $12.4M compared to $11.5M at December 31, 2011. | |
|
News For DRTX From The Last 14 Days Check below for free stories on DRTX the last two weeks. |
|
|
| May 9, 2013 | | 07:24 EDT | | DRTX | Durata Therapeutics reports Q1 EPS (86c), consensus (66c)
 Subscribe for More Information | |
|
|
|
|
|
|
